Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,313 | 10 | 99.6% |
| Food and Beverage | $35.06 | 2 | 0.3% |
| Education | $15.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Progenics Pharmaceuticals, Inc. | $7,875 | 9 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $3,438 | 1 | $0 (2021) |
| Advanced Accelerator Applications | $32.10 | 2 | $0 (2017) |
| Cardinal Health 414, LLC | $17.96 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $5,425 | 5 | Progenics Pharmaceuticals, Inc. ($5,425) |
| 2021 | $3,438 | 1 | Novartis Pharmaceuticals Corporation ($3,438) |
| 2020 | $2,450 | 4 | Progenics Pharmaceuticals, Inc. ($2,450) |
| 2017 | $50.06 | 3 | Advanced Accelerator Applications ($32.10) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 07/07/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,400.00 | General |
| 04/14/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 03/24/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| 03/24/2022 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| 12/17/2021 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $3,437.50 | General |
| 07/02/2020 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 06/05/2020 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $875.00 | General |
| 05/18/2020 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 05/18/2020 | Progenics Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| 05/12/2017 | Cardinal Health 414, LLC | Lymphoseek (Drug) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Hematology Oncology | ||||||
| 02/07/2017 | Advanced Accelerator Applications | NETSPOT (kit for the preparation of gallium Ga 68 dotatate for injection) (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Oncology | ||||||
| 02/06/2017 | Advanced Accelerator Applications | LUTATHERA (lutetium Lu 177 dotatate) (Drug) | Education | In-kind items and services | $15.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 791 | 812 | $1.1M | $198,353 |
| 2022 | 13 | 670 | 693 | $660,528 | $102,356 |
| 2021 | 13 | 786 | 802 | $915,615 | $151,842 |
| 2020 | 9 | 551 | 560 | $643,832 | $106,852 |
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 68 | 68 | $554,676 | $96,367 | 17.4% |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | Office | 2023 | 14 | 14 | $87,386 | $50,246 | 57.5% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 299 | 314 | $282,450 | $27,999 | 9.9% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2023 | 64 | 64 | $25,920 | $6,869 | 26.5% |
| 78816 | Nuclear medicine study whole body with ct scan | Facility | 2023 | 41 | 42 | $37,800 | $3,832 | 10.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 59 | 59 | $22,775 | $3,486 | 15.3% |
| 79101 | Radioactive drug therapy through a vein | Facility | 2023 | 19 | 21 | $9,513 | $1,548 | 16.3% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 43 | 46 | $8,898 | $1,324 | 14.9% |
| 78582 | Nuclear medicine study of lung ventilation and circulation | Facility | 2023 | 33 | 33 | $8,488 | $1,256 | 14.8% |
| 78429 | Nuclear medicine study of heart muscle with metabolic evaluation and concurrent ct scan | Facility | 2023 | 17 | 17 | $6,120 | $1,131 | 18.5% |
| 78830 | Nuclear medicine study, spect imaging with concurrent ct scan, 1 area or single acquisition, single day imaging | Facility | 2023 | 21 | 21 | $6,489 | $1,056 | 16.3% |
| 78430 | Nuclear medicine study of blood flow in heart muscle at rest and with stress with concurrent ct scan | Facility | 2023 | 15 | 15 | $5,100 | $916.35 | 18.0% |
| 78072 | Nuclear medicine study of parathyroid with spect and ct scan | Facility | 2023 | 14 | 14 | $4,704 | $741.12 | 15.8% |
| 78264 | Nuclear medicine study of stomach to assess emptying | Facility | 2023 | 21 | 21 | $4,053 | $565.20 | 13.9% |
| 78803 | Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging | Facility | 2023 | 13 | 13 | $3,458 | $522.53 | 15.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 50 | 50 | $8,400 | $493.23 | 5.9% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2022 | 35 | 35 | $285,495 | $54,698 | 19.2% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2022 | 250 | 265 | $238,500 | $24,991 | 10.5% |
| 78816 | Nuclear medicine study whole body with ct scan | Facility | 2022 | 55 | 58 | $52,200 | $5,493 | 10.5% |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | Office | 2022 | 43 | 44 | $6,160 | $4,674 | 75.9% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 54 | 54 | $19,710 | $3,391 | 17.2% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2022 | 62 | 64 | $11,600 | $2,140 | 18.5% |
| 78830 | Nuclear medicine study, 1 area with spect and concurrent ct scan | Facility | 2022 | 24 | 24 | $7,106 | $1,395 | 19.6% |
| 79101 | Radioactive drug therapy through a vein | Facility | 2022 | 11 | 13 | $5,889 | $1,037 | 17.6% |
| 78582 | Nuclear medicine study of lung ventilation and circulation | Facility | 2022 | 25 | 25 | $6,550 | $1,023 | 15.6% |
About Dr. Lilja Solnes, M.D
Dr. Lilja Solnes, M.D is a Nuclear Medicine healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1548309875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lilja Solnes, M.D has received a total of $11,363 in payments from pharmaceutical and medical device companies, with $5,425 received in 2022. These payments were reported across 13 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($11,313).
As a Medicare-enrolled provider, Solnes has provided services to 2,798 Medicare beneficiaries, totaling 2,867 services with total Medicare billing of $559,403. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Practice Information
- Specialty Nuclear Medicine
- Other Specialties Diagnostic Radiology
- Location Dallas, TX
- Active Since 02/05/2007
- Last Updated 02/06/2026
- Taxonomy Code 207U00000X
- Entity Type Individual
- NPI Number 1548309875
Products in Payments
- Lymphoseek (Drug) $17.96
- NETSPOT (kit for the preparation of gallium Ga 68 dotatate for injection) (Drug) $17.10
- LUTATHERA (lutetium Lu 177 dotatate) (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Medicine Doctors in Dallas
Dr. Martin Pomper, M.d., Ph.d, M.D., PH.D
Nuclear Medicine — Payments: $29,302
Dr. Anshul Agarwal, Md, Phd, MD, PHD
Nuclear Medicine — Payments: $2,773
Landis Griffeth, Phd Md, PHD MD
Nuclear Medicine — Payments: $1,707
Fangyu Peng, Md, MD
Nuclear Medicine — Payments: $147.12
Stanley Grossman, Md, MD
Nuclear Medicine — Payments: $136.98
Dr. Rosinda De La Pena, M.d, M.D
Nuclear Medicine — Payments: $80.39